Manufacturer record

Zydus Healthcare Limited: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Zydus Healthcare Limited (Gujarat) were declared Not of Standard Quality between May 2025 and October 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: N400726, Dexamethasone Sodium Phosphate Injection IP (Dexona) (exp Nov 2025). CDL, Kolkata (CDSCO lab) found it not of standard quality: Assay and Particulate matter, of Description. Listed in the October 2025 alert.

Records by type

2 records linked to Zydus Healthcare Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, May 2025 to Oct 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2025
1
Products affected
Assay
Most common failure
Oct 2025
Latest alert

Flagged batches per year

2025 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Dexamethasone Sodium Phosphate Injection IP (Dexona) Batch N400726Mfg Jun 2023 · Exp Nov 2025 Assay and Particulate matter, of Description.Assay CDL, KolkataCDSCO lab Oct 2025
Dexamethasone Sodium Phosphate Injection IP (Dexona) Batch N400726Mfg Jun 2024 · Exp Nov 2025 Particulate matter, Assay of Dexamethasone Phosphate and DescriptionAssay CDL, KolkataCDSCO lab May 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.